The convergence of technology and healthcare drives major growth worldwide, promoting healthier and better lives.
We connect our clients with innovative business leaders, scientific and technical experts in:
The digital health market is braced for significant growth, with sub-sector developments in different geographies worldwide. mHealth is predicted globally to be fastest growing segment in digital health, with collaborative partnerships bringing the multi-discipline approach of healthcare into the consumer environment.
This growth is based on the convergence of mobile and IoT technologies with healthcare services, creating ‘smart living’ that puts health and wellness directly into the hands of the individual.
In different geographies, emerging regional strengths are driven by partnerships between the private and public sector, talent pools and government policy. Parts of Europe are particularly strong in telehealthcare and EHR due to government policy, while the US is a leader in digital health systems. Markets with public healthcare systems such as Brazil, Canada and the UK will dominate expertise in analytics using data generated in their public health systems.
The more interconnected healthcare environment creates exciting opportunities but also challenges for leadership. Commercial, technical and scientific leaders need evolving skill sets and leadership capabilities. Board directors and business leaders need an ability to lead digital organizations while keeping on top of health economics and information governance. Technical and scientific leaders must be able to run work-streams in an environment with multiple influences – from competitive innovation to changes in consumer behaviour and further regulation.
Boyden partners have the experience, industry access and gravitas to deliver exceptional results. They are search experts, professional advisors and personal mentors.
We share our knowledge of topical issues in special reports, interviews and blogs. If you are interested in a specific topic, please ask your Boyden partner or contact our local office.
The impact of ESG investing is too significant to ignore and with the battle for funds at its peak, the biotech industry needs to be at the forefront of the agenda. With impending mandates, the pressure is firmly on businesses to start thinking about their ESG proposition and how it may positively influence and affect the wider industry.